Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

8.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.3K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

8.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Lineage Commitment01:21

Lineage Commitment

4.0K
Commitment is the  process whereby stem cells:
4.0K
Production of Formed Elements01:34

Production of Formed Elements

3.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Journal of the American Chemical Society·2026
Same author

<i>Ppm1d</i> Clonal Hematopoiesis Does Not Promote Atherosclerosis in Murine Models.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Clonal hematopoiesis in lung adenocarcinoma pathogenesis.

JCI insight·2026
Same author

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Blood·2026
Same author

Charged molecular glue discovery enabled by targeted degron display.

Nature chemical biology·2026
Same author

Endogenous aldehydes: A driver of clonal hematopoiesis from within?

Cell stem cell·2026

Related Experiment Video

Updated: Jan 1, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

13.8K

Clonal hematopoiesis as a model for premalignant changes during aging.

David P Steensma1, Benjamin L Ebert1

  • 1Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

Experimental Hematology
|December 16, 2019
PubMed
Summary

Somatic DNA mutations accumulate with age, leading to clonal expansion in healthy tissues. This clonal hematopoiesis increases risks for myeloid neoplasia and cardiovascular events, impacting public health.

More Related Videos

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.5K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.7K

Related Experiment Videos

Last Updated: Jan 1, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

13.8K
Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.5K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.7K

Area of Science:

  • Genetics
  • Aging Biology
  • Hematology

Background:

  • Somatic DNA mutations accumulate throughout the human lifespan in various tissues.
  • While often asymptomatic, some mutations confer a fitness advantage, promoting clonal expansion of stem cells.
  • Hematopoietic stem cells are particularly prone to clonal expansion due to their circulation and self-renewal capacity.

Purpose of the Study:

  • To explore the mechanisms of clonal hematopoiesis and its associated health risks.
  • To understand the distinct biological and clinical consequences of clonal expansion in blood cells.
  • To identify strategies for mitigating the adverse effects of clonal hematopoiesis.

Main Methods:

  • The study is primarily a review and synthesis of existing research on somatic mutations and clonal expansion.
  • It analyzes the unique characteristics of hematopoietic stem cells in the context of clonal selection.
  • The abstract discusses the progression from clonal expansion to neoplasia and other diseases.

Main Results:

  • Clonal expansion in hematopoietic stem cells can lead to myeloid or lymphoid neoplasia.
  • Clonal hematopoiesis is linked to non-neoplastic conditions, including cardiovascular events.
  • Mutant blood cell function contributes to disease pathogenesis.

Conclusions:

  • Understanding clonal hematopoiesis is crucial for aging biology and public health.
  • Further research into the origins and consequences of clonal hematopoiesis is warranted.
  • Developing interventions to prevent adverse outcomes of clonal hematopoiesis is a key future direction.